Nightingale Pharmaceuticals, Inc. — Form D/A
Nightingale Pharmaceuticals, Inc. of NATIONAL CITY, CA, a company, filed a Form D amendment with the SEC on 2016-03-25. The offering totals $2.0M, of which $1.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-03-25
- Form: D/A
- Accession: 0001078782-16-002494
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.7M
- Remaining: $335K
- Minimum investment: $10K
- Investors: 19
- Date of first sale: 2015-02-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-235337
Issuer
- Name: Nightingale Pharmaceuticals, Inc.
- CIK: 0001635548
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2015
- Address: 1999 SWEETWATER RD., NATIONAL CITY, CA, 91950
- Phone: 760-522-3345
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| MELWYN ABREO | Director | NATIONAL CITY, CA |
| LORENS ATTISHA | Director | NATIONAL CITY, CA |
| DAVID CHURCH | Director | NATIONAL CITY, CA |
| CAROL MCBRIDE | Director | NATIONAL CITY, CA |
| TALAL (BRIAN) SHEENA | Director | NATIONAL CITY, CA |
| MELWYN ABREO | Executive Officer | NATIONAL CITY, CA |
| LORENS ATTISHA | Executive Officer | NATIONAL CITY, CA |
| DAVID CHURCH | Executive Officer | NATIONAL CITY, CA |
| CAROL MCBRIDE | Executive Officer | NATIONAL CITY, CA |
| TALAL (BRIAN) SHEENA | Executive Officer | NATIONAL CITY, CA |
Other filings by this issuer (1)
More